Delivery Order SPE2DB20D2104-SPE2DB24FS22E
- Not listed
- This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR 100S capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $3,111.27. The award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 24,000 units of Creon DR 24,000 unit capsules. The firm-fixed-price delivery order, valued at $1,616.16, has a completion date of January 2, 2025. The contract is not designated as a set-aside and appears to be an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 24,000 units of Creon DR 100S capsules to the Defense Logistics Agency (DLA). The contract, valued at $3,081.38, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 14, 2023. The contract is a firm fixed-price delivery order with a completion date of June 15, 2023. The award was made through open competition, as there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.,...
- This federal contract award is for the delivery of 24,000 unit capsules of the pharmaceutical product CREON DR to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order with a ceiling value of $1,466.63. The award has an ultimate completion date of April 26, 2024. The contract is not designated with a set-aside and was awarded through full and open...
- This federal contract award is for the delivery of 36,000 unit capsules of the pharmaceutical product CREON DR to the United States government. The contract, valued at $8,914.46, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of September 21, 2023. The contract does not have a set-aside designation, indicating it was...
- This federal contract award is for the delivery of 24,000 unit capsules of the pharmaceutical product CREON DR over a period ending on October 31, 2023. The contract, with a ceiling value of $3,315.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of 6,000 units of Creon DR capsules (100 count bottles) to the Defense Logistics Agency (DLA). The $1,983.12 fixed-price delivery order was issued on October 26, 2021 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of October 27, 2021 and was not subject to any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $4,540.30, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and the ultimate completion date is May 9, 2024. The contract covers the delivery of 36,000 unit capsules of CREON DR, a pharmaceutical product, to support the DLA's medical supply requirements. This award is part of a larger...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product Creon DR. The award, valued at $7,323.00, has a period of performance through March 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00...
- This federal contract award is for the delivery of 36,000 units of Creon DR 100S capsules to the Defense Logistics Agency (DLA). The contract has a firm fixed price of $9,866.07 and a completion date of May 23, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS22EDelivery Order
This federal contract award is for the delivery of 36,000 unit capsules of the pharmaceutical product Creon DR to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $4,752.16. The award has an ultimate completion date of January 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is part of Amerisourcebergen's broader role as a critical supplier of essential medical commodities, including specialty medications, generic drugs, and medical devices, to various federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/25/24 |